Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5-year randomized controlled trial with 12-month follow-up

J Eur Acad Dermatol Venereol. 2022 Nov;36(11):e946-e948. doi: 10.1111/jdv.18374. Epub 2022 Jul 21.

Authors

K Togsverd-Bo¹, C Sandberg², P Helsing³, G Mørk³, A M Wennberg², H C Wulf¹, M Haedersdal¹

Affiliations

¹ Department of Dermato-Venerology, Bispebjerg University Hospital, Copenhagen, Denmark.
² Department of Dermato-Venerology, Sahlgrenska University Hospital, Gothenburg, Sweden.
³ Department of Dermato-Venerology, Oslo University Hospital, Oslo, Norway.

PMID: 35753046
DOI: 10.1111/jdv.18374

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Aminolevulinic Acid / therapeutic use
Follow-Up Studies
Humans
Keratosis, Actinic* / drug therapy
Kidney Transplantation*
Photochemotherapy*
Photosensitizing Agents / therapeutic use
Treatment Outcome

Substances

Photosensitizing Agents
Aminolevulinic Acid